The American Society of Hematology (ASH) is seeking comments on two additional draft clinical practice guidelines on sickle cell disease (SCD): pain and transplantation. All members of the public are invited to review the draft recommendations and submit comments, including physicians and researchers, allied professionals, industry and insurance company representatives, patients, caregivers, and general members of the public.
These guidelines are the fourth and fifth installments of five SCD guidelines expected to be published later this year. In 2018 three guidelines opened for public comment: transfusion support, cardiopulmonary and kidney disease, and cerebrovascular disease.
These guidelines were developed by ASH and supported by the Mayo Clinic Evidence-Based Practice Center using a process intended to meet recommendations by the Institute of Medicine. Recommendations were formed by guideline panels which included experts in SCD from multiple disciplines, methodologists, and patient representatives. No industry support was accepted to fund the development process. For more information, please visit the ASH clinical practice guidelines website.
Submit your comments by May 13 by clicking here. Feedback received during the comment period will be provided to the guideline panel for review.
Your feedback is essential to strengthen the content and credibility of the final guidelines. We thank you in advance for your participation.